ArticleThe American journal of case reports2022

A Case Report of a 58-Year-Old Woman with a Diagnosis of High-Risk Myeloma Refractory to Multiple Line of Therapy and Treated with Selinexor, Bortezomib, and Dexamethasone Prior to Allogeneic Stem Cell Transplantation.

Michael Cass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.